Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan.

作者: Tsuneyuki Takahashi , Peter J Barnes , Ivana Kawikova , Magdi H Yacoub , Timothy D Warner

DOI: 10.1016/S0014-2999(97)10008-5

关键词:

摘要: Abstract We have examined whether 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2,2′-bipyrimidin-4-yl]-benzenesulfonamide (bosentan; endothelin ETA/B receptor antagonist) and (R)2-[(R)-2-[(S)-2-[[1-(hexahydro-1H-azepinyl)]carbonyl] amino-4-methylpentanoil]amino-3-[3-(1-methyl-1H-indoyl)]propionyl]amino-3-(2-pyridyl) propionic acid (FR 139317; ETA inhibit contractions of human airway smooth muscle induced by endothelin-1 or Suc-[Glu9,Ala11,15]enthothelin-1-(8–21) (IRL 1620; ETB agonist). Endothelin-1 IRL 1620 were equipotent. Bosentan FR 139317 (each 10 μM) produced a small shift in response curves to (1.6- 1.5-fold, respectively). However, bosentan was more potent against elicited (10 μM, 11.2-fold shift) suggesting that these agonists exhibit different kinetic interactions with receptors implying an interaction novel subtype airways.

参考文章(17)
W Spielman, M Pullen, P Nambi, Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors. Journal of Pharmacology and Experimental Therapeutics. ,vol. 268, pp. 202- 207 ,(1994)
W Neidhart, M Clozel, B M Löffler, G A Gray, V Breu, K Burri, M Müller, G Hirth, J M Cassal, B Kalina, Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics. ,vol. 270, pp. 228- 235 ,(1994)
D.W.P. Hay, M.A. Luttmann, W.C. Hubbard, B.J. Undem, Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. British Journal of Pharmacology. ,vol. 110, pp. 1175- 1183 ,(1993) , 10.1111/J.1476-5381.1993.TB13938.X
C. Advenier, B. Sarria, E. Naline, L. Puybasset, V. Lagente, Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. British Journal of Pharmacology. ,vol. 100, pp. 168- 172 ,(1990) , 10.1111/J.1476-5381.1990.TB12071.X
S.A. Sudjarwo, M. Hori, T. Tanaka, Y. Matsuda, T. Okada, H. Karaki, Subtypes of endothelin ETA and ETB receptors mediating tracheal smooth muscle contraction. Biochemical and Biophysical Research Communications. ,vol. 200, pp. 627- 633 ,(1994) , 10.1006/BBRC.1994.1494
Hiroshi Arai, Seiji Hori, Ichiro Aramori, Hiroaki Ohkubo, Shigetada Nakanishi, Cloning and expression of a cDNA encoding an endothelin receptor Nature. ,vol. 348, pp. 730- 732 ,(1990) , 10.1038/348730A0
D.W.P. Hay, M.A. Luttmann, G. Beck, E.H. Ohlstein, Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus. British Journal of Pharmacology. ,vol. 118, pp. 1209- 1217 ,(1996) , 10.1111/J.1476-5381.1996.TB15525.X
Bruno Battistini, Timothy D. Warner, Alain Fournier, John R. Vane, Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620 European Journal of Pharmacology. ,vol. 252, pp. 341- 345 ,(1994) , 10.1016/0014-2999(94)90184-8
R G Goldie, P J Henry, P G Knott, G J Self, M A Luttmann, D W Hay, Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways. American Journal of Respiratory and Critical Care Medicine. ,vol. 152, pp. 1653- 1658 ,(1995) , 10.1164/AJRCCM.152.5.7582310